Last update:

Oncology & Cancer news

Oncology & Cancer

Lymph nodes found to be key to successful cancer immunotherapy

A team of researchers, led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute), explored the cellular and molecular interactions revealing how lymph nodes play a crucial role in the fight against ...

Oncology & Cancer

Investigating how tumor-immune cell clusters drive breast cancer spread

In a pair of studies, investigators from the lab of Huiping Liu, MD, Ph.D., associate professor of Pharmacology and of Medicine in the Division of Hematology and Oncology, have uncovered how specific cellular interactions ...

Oncology & Cancer

Remote monitoring can improve recovery from cancer surgery

A new study co-authored by Tracy Crane, Ph.D., RDN, co-leader of the Cancer Control Program at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, shows that remote perioperative ...

Oncology & Cancer

Blood test to rule out esophageal cancer

Proteomics International has launched PromarkerEso at the ISDE World Congress in Brisbane (18–20 September). PromarkerEso is a world-first protein biomarker-based blood diagnostic that can rule out esophageal adenocarcinoma ...

Oncology & Cancer

Getting the facts on ovarian cancer

Ovarian cancer is relatively rare. However, it's often fatal in later stages of the disease. The cancer begins in the ovaries and spreads to the abdomen and pelvis if it isn't diagnosed and treated early. It primarily affects ...

Oncology & Cancer

Autoimmune diseases linked to cancers of the digestive tract

In a comprehensive study, researchers from the Department of Epidemiology at the Faculty of Medicine at the University of Augsburg have provided reliable evidence for a link between chronic inflammatory diseases and the development ...

Oncology & Cancer

Study reveals targeted therapy for aggressive liver cancer

Among the many forms of liver cancer, hepatocellular carcinoma (HCC) is the most common and one of the leading causes of cancer-related deaths worldwide. It is a complex disease with multiple aggressive subtypes that are ...

Medications

Boehringer wins US approval for cancer drug

Boehringer Ingelheim GmbH won approval in the U.S. for its drug to treat a challenging form of lung cancer, offering a growth avenue for the privately-held German pharmaceuticals company.